![4-[(4-Methylpiperazin-1-yl)methyl]benzoic asid dihydrochloride CAS 106261-49-8 Imatinib Mesylate Entèmedyè Pite Segondè Imaj Prezantasyon](https://www.ruifuchemical.com/uploads/d1fa2a19.jpg)
4-[(4-Methylpiperazin-1-yl)methyl]benzoik asid dihydrochloride CAS 106261-49-8 Imatinib Mesylate Entèmedyè Pite segondè
Pwovizyon Komèsyal Imatinib Mesylate ak entèmedyè ki gen rapò:
Imatinib Mesylate CAS: 220127-57-1
N-(2-Methyl-5-nitrophenyl)-4-(piridin-3-yl)pyrimidin-2-amine CAS: 152460-09-8
N-(5-Amino-2-methylphenyl)-4-(3-pyridyl)-2-pyrimidinea CAS: 152460-10-1
4-[(4-Methylpiperazin-1-yl)methyl]benzoic asid dihydrochloride CAS: 106261-49-8
| Non Chimik | 4-[(4-Methylpiperazin-1-yl)methyl]benzoik asid dihydrochloride |
| Sinonim | Imatinib Mesylate Entèmedyè |
| Nimewo CAS | 106261-49-8 |
| Nimewo CAT | RF-PI229 |
| Estati Stock | Nan Stock, Pwodiksyon Echèl Jiska Tòn |
| Fòmil molekilè | C13H20Cl2N2O2 |
| Pwa molekilè | 307.22 |
| Pwen k ap fonn | 305.0 ~ 307.0 ℃ |
| Solibilite | Soluble nan dlo |
| Mak | Ruifu Chimik |
| Atik | Espesifikasyon |
| Aparans | Blan prèske blan poud kristal |
| Pite / Metòd analiz | ≥98.0% (HPLC) |
| Pèt sou siye | ≤0.50% |
| Rezid sou ignisyon | ≤0.50% |
| Enpurte total | ≤2.0% |
| Maksimòm sèl enpurte | ≤1.0% |
| Tès Creole | Enterprise Standard |
| Itilizasyon | Famasetik Entèmedyè Imatinib Mesylate (CAS: 220127-57-1) |
Pake: Boutèy, sak papye aliminyòm, tanbou katon, 25kg / tanbou, oswa selon kondisyon kliyan an.
Kondisyon Depo:Sere nan resipyan ki fèmen nan yon kote ki fre ak sèk;Pwoteje kont limyè, imidite ak ensèk nuizib.
Shanghai Ruifu Chemical Co, Ltd se manifakti dirijan ak founisè nan 4-[(4-Methylpiperazin-1-yl)methyl]benzoic asid dihydrochloride (CAS: 106261-49-8) ak kalite siperyè.Lise yon entèmedyè tipikman nan sentèz Imatinib Mesylate (CAS: 220127-57-1).Imatinib Mesylate se yon inibitè tirozin kinaz, trè espesifik pou BCR-ABL, yon dwòg oral pou tretman pasyan adilt ki gen kwomozòm Philadelphia pozitif kwonik myeloid lesemi (CML) nan faz egi a ak sèten fòm lesemi lenfoblastik egi (ALL), akselere. faz ak faz kwonik apre echèk nan terapi entèferon.
![4-[(4-Methylpiperazin-1-yl)methyl]benzoik asid dihydrochloride CAS 106261-49-8 Imatinib Mesylate Entèmedyè Pite segondè](https://www.ruifuchemical.com/uploads/d1fa2a19-300x300.jpg)